Interleukin 1 modulates messenger RNA levels of lymphokines and of other molecules associated with T cell activation in the T cell lymphoma LBRM33-1A5. [PDF]
, 1987 Hajime Hagiwara +5 more
openalex +1 more source
Lifileucel: FDA-approved T-cell therapy for melanoma. [PDF]
OncologistKwong MLM, Yang JC.
europepmc +1 more source
Priming and triggering of tumoricidal and schistosomulicidal macrophages by two sequential lymphokine signals: interferon-gamma and macrophage cytotoxicity inducing factor 2. [PDF]
, 1985 Peter H. Krammer +3 more
openalex +1 more source
Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts. [PDF]
, 1988 Alan Kawarai Lefor +2 more
openalex +1 more source
Lysis of herpesvirus-infected cells by macrophages activated with free or liposome-encapsulated lymphokine produced by a murine T cell hybridoma [PDF]
, 1983 Wayne C. Koff +3 more
openalex +1 more source
Use of serum-free media for peripheral blood mononuclear cell culture and the impact on T and B cell readouts. [PDF]
Front ToxicolCochrane S, Saib O, Sheffield D.
europepmc +1 more source
Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response. [PDF]
, 1985 S S Yang +3 more
openalex +1 more source
Efficacy of cell-based immunotherapies on patients with glioma: an umbrella review of systematic reviews and meta-analysis protocol. [PDF]
BMJ Open, 2023 Nikoobakht M +10 more
europepmc +1 more source